Published in J Neurochem on November 27, 2016
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
The bases of the nucleic acids of some bacterial and animal viruses: the occurrence of 5-hydroxymethylcytosine. Biochem J (1953) 10.36
HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21
Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging (1995) 6.86
Recognition and estimation of 5-methylcytosine in nucleic acids. Biochem J (1951) 6.66
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
Global epigenomic reconfiguration during mammalian brain development. Science (2013) 6.14
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 6.12
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A (2004) 5.65
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci U S A (2005) 4.59
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell (2012) 4.56
5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci (2011) 4.15
Alzheimer's disease: genotypes, phenotypes, and treatments. Science (1997) 3.72
Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell (2012) 3.65
"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci (2014) 2.85
Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS One (2011) 2.80
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci (2014) 2.36
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11
On the presence and role of human gene-body DNA methylation. Oncotarget (2012) 2.10
Epigenetics of autism spectrum disorders. Hum Mol Genet (2006) 2.03
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem (2005) 1.88
Heat-induced formation of reactive oxygen species and 8-oxoguanine, a biomarker of damage to DNA. Nucleic Acids Res (2002) 1.82
Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging (2008) 1.60
Variation in 5-hydroxymethylcytosine across human cortex and cerebellum. Genome Biol (2016) 1.59
Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med (2009) 1.56
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem (2006) 1.52
Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS One (2012) 1.48
Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J Biol Chem (2013) 1.43
Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging (2013) 1.37
Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol (2014) 1.36
Cellular background level of 8-oxo-7,8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis (2002) 1.36
Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain (2010) 1.35
Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry (2012) 1.31
Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis (2012) 1.27
The curious chemical biology of cytosine: deamination, methylation, and oxidation as modulators of genomic potential. ACS Chem Biol (2011) 1.25
Determination of 8-oxoguanine in DNA by gas chromatography--mass spectrometry and HPLC--electrochemical detection: overestimation of the background level of the oxidized base by the gas chromatography--mass spectrometry assay. Chem Res Toxicol (1995) 1.19
The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res (2012) 1.16
Analysis of modified bases in DNA by stable isotope dilution gas chromatography-mass spectrometry: 5-methylcytosine. Anal Biochem (1983) 1.15
Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol Aging (2013) 1.15
Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning. Aging (Albany NY) (2015) 1.14
Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging (2012) 1.10
Quantitative determination of 8-hydroxyguanine and guanine by isotope dilution mass spectrometry. Anal Biochem (1995) 1.00
Inter-individual variability contrasts with regional homogeneity in the human brain DNA methylome. Nucleic Acids Res (2015) 1.00
Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev (2013) 0.97
Gene expression reveals overlap between normal aging and Alzheimer's disease genes. Neurobiol Aging (2010) 0.97
Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation. Cell Death Dis (2014) 0.97
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med (2012) 0.96
Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin (2015) 0.93
Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging (2014) 0.93
Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism. Nucleic Acids Res (2013) 0.91
Genomic distribution and possible functions of DNA hydroxymethylation in the brain. Genomics (2014) 0.91
Epigenetics of aging and aging-related disease. J Gerontol A Biol Sci Med Sci (2014) 0.91
Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain. Neurobiol Aging (2014) 0.91
Selected-ion mass spectrometry: assays of oxidative DNA damage. Methods Enzymol (1990) 0.91
Elevated 5-hydroxymethylcytosine in the Engrailed-2 (EN-2) promoter is associated with increased gene expression and decreased MeCP2 binding in autism cerebellum. Transl Psychiatry (2014) 0.91
Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol Aging (2014) 0.91
Widespread existence of cytosine methylation in yeast DNA measured by gas chromatography/mass spectrometry. Anal Chem (2012) 0.90
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment. Aging Dis (2015) 0.90
Development and validation of a gas chromatography/mass spectrometry method for the assessment of genomic DNA methylation. Rapid Commun Mass Spectrom (2009) 0.88
Measurement of oxidative DNA damage by gas chromatography-mass spectrometry: ethanethiol prevents artifactual generation of oxidized DNA bases. Biochem J (1998) 0.87
Role of 5-hydroxymethylcytosine in neurodegeneration. Gene (2015) 0.87
Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase. J Biol Chem (2013) 0.86
Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm. Curr Alzheimer Res (2012) 0.83
Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease. Neuropathol Appl Neurobiol (2015) 0.80
Epigenetics of Alzheimer's disease and frontotemporal dementia. Neurotherapeutics (2013) 0.80
Measurement of DNA methylation using stable isotope dilution and gas chromatography-mass spectrometry. Anal Biochem (2005) 0.80
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression. Brain (2015) 0.79
5-methylcytosine and its derivatives. Adv Clin Chem (2014) 0.79
Gas chromatography-mass spectrometry analysis of DNA: optimization of protocols for isolation and analysis of DNA from human blood. Methods Enzymol (2000) 0.79
Integrated whole transcriptome and DNA methylation analysis identifies gene networks specific to late-onset Alzheimer's disease. J Alzheimers Dis (2015) 0.79
Alzheimer's loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol (2015) 0.79
Hydroxyl-radical-induced oxidation of 5-methylcytosine in isolated and cellular DNA. Nucleic Acids Res (2014) 0.78
Epigenetic modifications as novel therapeutic targets for Huntington's disease. Epigenomics (2014) 0.77
Longitudinal epigenetic and gene expression profiles analyzed by three-component analysis reveal down-regulation of genes involved in protein translation in human aging. Nucleic Acids Res (2015) 0.76
Understanding the complexity of antigen retrieval of DNA methylation for immunofluorescence-based measurement and an approach to challenge. J Immunol Methods (2014) 0.76
Global and Site-Specific Changes in 5-Methylcytosine and 5-Hydroxymethylcytosine after Extended Post-mortem Interval. Front Genet (2016) 0.76